Related Experiment Videos
Substrate analogues to study cell-wall biosynthesis and its inhibition
1Department of Chemistry, Princeton University, Princeton, New Jersey 08544, USA. klazar@princeton.edu
Current Opinion in Chemical Biology
|December 10, 2002
Summary
Lipid II, a key intermediate in peptidoglycan synthesis, is a crucial target for antibiotics like glycopeptides and lantibiotics. New synthetic intermediates aid in studying peptidoglycan enzymes and antibiotic mechanisms.
Area of Science:
- Microbiology
- Biochemistry
- Medicinal Chemistry
Background:
- Lipid II has been recognized as a peptidoglycan synthesis intermediate for over 30 years.
- Recent studies highlight Lipid II as a significant target for various antibiotics, including glycopeptides, lantibiotics, and ramoplanin.
- Sortases utilize Lipid II in Gram-positive cell wall construction.
Purpose of the Study:
- To synthesize novel peptidoglycan intermediates.
- To facilitate the study of peptidoglycan biosynthesis enzymes.
- To investigate the mechanisms of action for substrate-binding antibiotics targeting Lipid II.
Main Methods:
- Chemical synthesis of peptidoglycan precursors.
- Enzymatic assays for peptidoglycan synthesis.
- Antibiotic mechanism of action studies using synthetic substrates.
Main Results:
- Successful synthesis of novel peptidoglycan intermediates.
- Demonstrated utility of these intermediates in studying peptidoglycan enzymes.
- Enabled detailed investigation into how antibiotics bind and inhibit their targets.
Conclusions:
- Synthetic peptidoglycan intermediates are valuable tools for biochemical and mechanistic studies.
- Understanding Lipid II biosynthesis and antibiotic interactions is crucial for developing new antibacterial therapies.
- This research advances the study of cell wall synthesis and antibiotic resistance.